1. Home
  2. BCDA vs MWG Comparison

BCDA vs MWG Comparison

Compare BCDA & MWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • MWG
  • Stock Information
  • Founded
  • BCDA N/A
  • MWG 1988
  • Country
  • BCDA United States
  • MWG Singapore
  • Employees
  • BCDA N/A
  • MWG N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • MWG Miscellaneous manufacturing industries
  • Sector
  • BCDA Health Care
  • MWG Consumer Discretionary
  • Exchange
  • BCDA Nasdaq
  • MWG Nasdaq
  • Market Cap
  • BCDA 7.9M
  • MWG 8.7M
  • IPO Year
  • BCDA N/A
  • MWG 2023
  • Fundamental
  • Price
  • BCDA $1.85
  • MWG $0.24
  • Analyst Decision
  • BCDA Strong Buy
  • MWG
  • Analyst Count
  • BCDA 1
  • MWG 0
  • Target Price
  • BCDA $25.00
  • MWG N/A
  • AVG Volume (30 Days)
  • BCDA 61.9K
  • MWG 185.2K
  • Earning Date
  • BCDA 11-13-2024
  • MWG 01-01-0001
  • Dividend Yield
  • BCDA N/A
  • MWG N/A
  • EPS Growth
  • BCDA N/A
  • MWG 54.92
  • EPS
  • BCDA N/A
  • MWG 0.06
  • Revenue
  • BCDA $71,000.00
  • MWG $36,016,000.00
  • Revenue This Year
  • BCDA $6.92
  • MWG N/A
  • Revenue Next Year
  • BCDA N/A
  • MWG N/A
  • P/E Ratio
  • BCDA N/A
  • MWG $3.91
  • Revenue Growth
  • BCDA N/A
  • MWG N/A
  • 52 Week Low
  • BCDA $1.84
  • MWG $0.20
  • 52 Week High
  • BCDA $12.00
  • MWG $0.78
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 29.98
  • MWG 37.40
  • Support Level
  • BCDA $2.21
  • MWG $0.25
  • Resistance Level
  • BCDA $2.47
  • MWG $0.28
  • Average True Range (ATR)
  • BCDA 0.16
  • MWG 0.02
  • MACD
  • BCDA -0.04
  • MWG 0.00
  • Stochastic Oscillator
  • BCDA 1.30
  • MWG 7.26

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About MWG Multi Ways Holdings Limited

Multi Ways Holdings Ltd is a supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region. The wide variety of new and used heavy construction equipment for sale and rental by customers range from: earth-moving equipment such as bulldozers, off-terrain dump trucks, excavators and wheel loaders; material-handling equipment such as crawler cranes, rough terrain cranes, scissor lifts, forklifts, boom-lifts and telescopic handlers; road-building equipment such as motor graders, vibrating compactors, asphalt finishers, skid loaders, backhoe loaders, hand rollers and mini excavators; and generators and compressors, such as air compressors, generators, lighting towers and welding machines.

Share on Social Networks: